Trial Profile
Decreasing Rates of Intraurethral Catheterization Postoperatively in Spine Surgery
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Feb 2022
Price :
$35
*
At a glance
- Drugs Tamsulosin (Primary)
- Indications Urinary retention
- Focus Therapeutic Use
- Acronyms DRIPS
- 18 Nov 2020 Status changed from recruiting to completed.
- 20 Mar 2018 Planned number of patients changed from 500 to 550.
- 20 Mar 2018 Planned End Date changed from 1 Mar 2019 to 1 Sep 2020.